Narrow your search

Library

KU Leuven (20)

VDIC (20)

Vlerick Business School (6)


Resource type

undetermined (26)


Language

English (26)


Year
From To Submit

2021 (1)

2020 (6)

2019 (3)

2018 (7)

2017 (2)

More...
Listing 1 - 10 of 26 << page
of 3
>>
Sort by
Medicare Part B : enrollment and premiums
Authors: ---
Year: 2018 Publisher: [Washington, D.C.] : Congressional Research Service,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Follow-on biologics: intellectual property issues
Authors: ---
Year: 2018 Publisher: [Washington, D.C.] : Congressional Research Service,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The future of branding within the pharmaceutical industry
Author:
Year: 2009 Publisher: London : Henry Stewart Talks,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Prescription drug discount coupons and patient assistance programs (PAPs)
Authors: ---
Year: 2018 Publisher: [Washington, D.C.] : Congressional Research Service,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The Prescription Drug User Fee Act : history through the 2007 PDUFA IV reauthorization
Authors: ---
Year: 2020 Publisher: [Washington, D.C.] : Congressional Research Service,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The role of patents and regulatory exclusivities in pharmaceutical innovation
Authors: ---
Year: 2018 Publisher: [Washington, D.C.] : Congressional Research Service,

Loading...
Export citation

Choose an application

Bookmark

Abstract

The Proposed Drug Quality and Security Act (H.R. 3204)
Authors: ---
Year: 2020 Publisher: [Washington, D.C.] : Congressional Research Service,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Pricing strategies : the case of a pharmaceutical company
Author:
Year: 2020 Publisher: London : Henry Stewart Talks,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This case study looks at different pricing strategies and uses the example of a pharmaceutical company to illustrate how to choose the right one for a given product.

National drug code directory
Author:
Year: 2001 Publisher: Silver Spring, MD : U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, Division of Data Management and Services

Loading...
Export citation

Choose an application

Bookmark

Abstract

"Drug establishments are required to provide FDA with a current list of all drugs manufactured, prepared, propagated, compounded or processed for sale in the U.S. at their facilities. Drugs are identified and reported using a unique, three-segment number called the National Drug Code (NDC) which serves as the FDA's identifier for drugs. FDA publishes the listed NDC numbers in the NDC Directory which is updated daily"--Background information.

Patents and regulatory exclusivities: issues in pharmaceutical innovation and competition
Authors: ---
Year: 2018 Publisher: [Washington, D.C.] : Congressional Research Service,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Listing 1 - 10 of 26 << page
of 3
>>
Sort by